While pembrolizumab is an approved treatment for patients with stage III non-small cell lung cancer (NSCLC), only some patients respond to this therapy. Treatment failure, researchers say, is often caused by differences in the tumor microenvironment.
How machine learning is accelerating research in structural biology
For Lucas Farnung, there is no question more fascinating than how a single fertilized egg develops into a fully-functioning human.
August 2, 2024